Results 191 to 200 of about 28,020 (301)

Ethnic differences in the comparative effectiveness of second‐line type 2 diabetes medications in preventing cardiovascular disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To investigate ethnic differences in the comparative effectiveness of sulfonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) on cardiovascular outcomes. Materials and Methods We identified adults with type 2 diabetes in UK electronic health records initiating SU, DPP4i or SGLT2i
Mia Harley, Christopher T. Rentsch, Elizabeth Williamson, Anoop S. V. Shah, Patrick Bidulka, Charlotte Warren‐Gash, Marleen Bokern, Rohini Mathur   +7 more
wiley   +1 more source

Corneal Nerve Morphology in Painful Diabetic Neuropathy: A Meta-Analysis of In Vivo Confocal Microscopy Studies. [PDF]

Biomedicines
Vidyasagar P, Farrell SF, Colorado LH, Dando S, Edwards K.   +4 more
europepmc   +1 more source

Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations

Christina Brock, Henning Andersen, Amra Ciric Alibegovic, S ren Due Andersen, Lars Vibe Andreasen, Morten Charles, Diana Hedevang Christensen, AM Drewes, M.-A. Gall, Sandra Sif Gylfadottir, Christian Stevns Hansen, S K Hecquet, Troels S. Jensen, Páll Karlsson, Lisbet Knudsen, Cirley Lobato, Huda Kufaishi, Haïfa Maalmi, H I Mizrak, Kristian Bernhard Nilsen, Ba Perkins, Johan Røikjer, Peter Rossing, Joergen Rungby, John Rømer, Anders Stouge, Karolina Sulek, Eirik Søfteland, Abd A. Tahrani, Astrid Juhl Terkelsen, Solomon Tesfaye, Anne‐Marie Wegeberg, Thorbjörn Åkerström, Birgitte Brock, Rodica Pop‐Busui   +34 more
openalex   +1 more source

Continuous glucose monitoring and microvascular complications in diabetes: Bridging glycemic metrics with clinical outcomes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Continuous glucose monitoring (CGM) has emerged as a complementary and more dynamic method for evaluating glycemic control in people with diabetes. Relevant studies examining the association between CGM parameters, including time in range (TIR), glycemic variability (GV), and time in tight range (TITR), and diabetic nephropathy, retinopathy ...
Lilian Anagnostopoulou, Alexandros L. Liarakos, Ioannis Ntanasis‐Stathopoulos, Alexandros Briasoulis, Anastasios Tentolouris   +4 more
wiley   +1 more source

Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub-Saharan African Cohort. [PDF]

J Peripher Nerv Syst
Chokote SE, Lemdjo G, Idiaquez Rios JF, Anakeu AT, Ngarka L, Nfor LN, Mengnjo MK, Njamnshi WY, Kengni HNT, Ngongang RJ, Simeni G, Piameu L, Nkonda AB, Yepnjio F, Tatah GY, Thirugnanam UN, Njamnshi AK.   +16 more
europepmc   +1 more source

Diabetic Neuropathy [PDF]

Diabetes, 1956
openaire   +2 more sources

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome

British Journal of Haematology, EarlyView.
Clément Triaille, Julie Beauchemin, Philippe M. Campeau, Hugo Chapdelaine, Julie Dery, Maria Kondyli, Grant Mitchell, Julie Powell, Sophie Turpin, Guilhem Cros, Fabien Touzot   +10 more
wiley   +1 more source

Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Published literature has raised concerns regarding a causal association between glucagon‐like peptide 1 receptor agonist (GLP‐1RA) use and thyroid cancer risk in adults. In this analysis, we evaluated the association between thyroid cancer risk and GLP‐1RA use.
Tina Vilsbøll, Michael Stellfeld, Vanita R. Aroda, Sune Dandanell, Jens‐Peter David, Ceyda T. P. Kristiansen, Søren Rasmussen, Fiona L. Roberts, Laszlo Hegedüs   +8 more
wiley   +1 more source

Characteristics and outcomes of cubital tunnel decompression in diabetic patients receiving glucagon-like peptide-1 receptor agonists. [PDF]

Clin Shoulder Elb
Shabbir R, Shamith S, Parente PEL, Nicholson L, Ali A.   +4 more
europepmc   +1 more source

Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Objective We aim to compare second‐generation automated insulin delivery systems (AIDs) with other treatment modalities regarding both glucose management outcomes and person‐reported outcomes/experiences (PROs/PREs, measured by the Hypoglycemia Fear Survey, Hypoglycemic Confidence Scale, Hyperglycemia Avoidance Scale, Diabetes Distress Scale ...
Zekai Wu, Laure Alexandre‐Heymann, Maha Lebbar, Meryem K. Talbo, Aude Bandini, Tamanna Chahal, Caroline Grou, Virginie Messier, Valérie Boudreau, Anne‐Sophie Brazeau, Rémi Rabasa‐Lhoret   +10 more
wiley   +1 more source